Artificial sweetener maker NutraSweet Co said on Wednesday it would exit its aspartame business by the end of the year, citing increasing foreign competition.
Home genetics startup 23andMe has secured a $1.4 million two-year grant from the National Institutes of Health (NIH) to build survey tools and expand its gene database.
Ranbaxy Laboratories has recalled 64,000 bottles of its generic version of Lipitor in the US after a 20-milligram tablet was found in a bottle for 10-milligrams, Reuters reported.
California, US-based innovative diabetes management startup Glooko landed $7 million in a funding round led by Samsung Venture Investment Company and Lifeforce Ventures to expand its predictive diabetes care service.
23andMe Chief Executive Officer Anne Wojcicki defended her company's genetic testing product and stands by the data on the accuracy of their results after the public warning letter issued by the US Food and Drug Administration.
Friday is the first day of sales for Sony's PlayStation 4 interactive gaming console. GE holds an meeting for investors and analysts focused on its GE Capital business. The Federal Reserve releases its report on U.S. industrial production.
Warner Chilcott has received FDA approval for oral contraceptive LO Minastrin FE.
Subscribe to VCpost newsletter
Most Popular
- Tesla Shareholder Votes Against Elon Musk’s $55 Billion Pay Package, Says 'Tyrant CEO' Abandons EV Maker for His Other Firms
- IMF Criticizes Joe Biden's Ramping Up Chinese Import Tariffs, Says US Should Work With China to Resolve Disputes
- AT&T, Verizon, and T-Mobile to Pay $10 Million Settlement Over Misleading Claims About ‘Unlimited’ Plans
- SNAP Benefits 2024: Storm-Affected Residents to Receive Replacement Applications, Extended Deadline
- Scam Warning: This is the Most Common Time People Were Likely to Get Victimized
- Visa to Change Credit, Debit Card Operations in US
- Investment Banker at Bank of America Dies from Blood Clot, Cited 100-Hour Weeks as Reason for Wanting to Leave
- EU Slaps Microsoft with Warning that it Could Face Billions of Fines Over Missing Generative AI Risk Report